Last reviewed · How we verify

NCT03174249: ETHICS

Exposure Therapy Combined With Cortical Interventions for CRPS-II

Completed NA Last updated 2 June 2017
What this trial tests

NA trial testing Exposure therapy in Complex Regional Pain Syndromes in 4 participants. Completed in 1 June 2015.

Timeline
1 September 2012
Primary endpoint
1 June 2015
1 June 2015

Quick facts

Lead sponsorUppsala University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment4
Start date1 September 2012
Primary completion1 June 2015
Estimated completion1 June 2015
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Uppsala University

Who can join

Adults 18 to 70, any sex, with Complex Regional Pain Syndromes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Consecutive patients with long-standing complex regional pain syndrome II in a lower limb are treated with graded exposure therapy in vivo in combination with methods targeting cortical reorganisation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Exposure therapy

Trials testing the same drug.

Other recruiting trials for Complex Regional Pain Syndromes

Currently open trials in the same condition.

Other Uppsala University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03174249.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing